INVEGA

Drug Janssen Pharmaceuticals, Inc
Total Payments
$297,365
Transactions
3,311
Doctors
1,613
Companies
3

Payment Trends by Year

Year Amount Transactions Doctors
2024 $95,698 1,690 759
2023 $75,511 683 388
2022 $25,270 184 133
2021 $49,504 108 85
2020 $495.09 10 10
2019 $1,981 73 66
2018 $2,943 500 419
2017 $45,961 63 17

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $96,970 27 32.6%
Food and Beverage $94,826 2,668 31.9%
Consulting Fee $87,865 45 29.5%
Travel and Lodging $14,897 40 5.0%
Education $2,806 531 0.9%

Top Doctors Receiving Payments for INVEGA — Page 65

Doctor Specialty Location Total Records
, M.D Psychiatry Queens Village, NY $4.55 1
, MD Psychiatry Rockville Centre, NY $4.55 1
, MD Psychiatry Brooklyn, NY $4.55 1
, MD Psychiatry Quincy, IL $4.55 1
, MD Psychiatry Beverly Hills, CA $4.55 1
Harinder Bansal Pottstown, PA $4.55 1
John Kohut San Bernardino, CA $4.55 1
Vasantha Badhey Psychiatry Flushing, NY $4.55 1
, MD Psychiatry Phoenixville, PA $4.55 1
, MD Family Medicine Custer, SD $2.18 1
, MD Family Medicine Custer, SD $2.18 1
, MD Family Medicine Custer, SD $2.18 1
, MD Family Medicine Clearwater, FL $1.74 1
, PMHNP Medical-Surgical Washington, DC $1.65 1

About INVEGA

INVEGA is a drug associated with $297,365 in payments to 1,613 healthcare providers, recorded across 3,311 transactions in the CMS Open Payments database. The primary manufacturer is Janssen Pharmaceuticals, Inc.

Payment data is available from 2017 to 2024. In 2024, $95,698 was paid across 1,690 transactions to 759 doctors.

The most common payment nature for INVEGA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($96,970, 32.6% of total).